Company Summary
Search
Home Page
 
RepliCel Life Sciences Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31HaltN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
24/Apr/1967  Canada British Columbia  
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research And Development In The Life Sciences  News Release July 17, 2014-RepliCel is a regenerative medicine company focused on developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function such as chronic tendinosis, damaged skin and pattern baldness. The company's RCT-01 and RCS-01 cell therapies are designed to treat chronic tendinosis and damaged or aging skin respectively, using fibroblasts isolated from the sheath of the hair follicle. Another of the company's pipeline products, RCH-01 for the treatment of pattern baldness, is manufactured from cells derived from the hair follicle dermal cup. Shiseido Company, Limited has an exclusive geographic license for RCH-01 in certain Asian countries including Japan, China and South Korea. All product candidates are based on RepliCel's innovative technology which utilizes cells isolated from a patient's own healthy hair follicles to address specific cellular deficits. 
Securities
SymbolSecurity NameMarketStatus
RPReplicel Life Sciences Inc.TSX VentureHALT
Name HistoryFromTo
RepliCel Life Sciences Inc.26/Jul/2013Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  BDO Canada LLP
Sponsor:  Canaccord Genuity Corp.
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  23/Dec/2019  NEWS RELEASE - REPLICEL ANNOUNCES ITS INCOMING BOARD OF DIRECTORS[CANADA NEWSWIRE]
    NEWS RELEASE - REPLICEL PROVIDES 2019 YEAR-END UPDATE[CANADA NEWSWIRE]
    NEWS RELEASE - CLINICAL DATA PUBLISHED FROM REPLICEL'S SKIN REJUVENATION STUDY[CANADA NEWSWIRE]
Bulletins  15/Mar/2024  Halt
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data